-
1
-
-
77949489688
-
-
Summary Report WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), Geneva: World Health Organization, (accessed 11 October 2010)
-
WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in South Africa. Summary Report. Geneva: World Health Organization, 2010. http://www.who.int/hpvcentre (accessed 11 October 2010).
-
(2010)
Human Papillomavirus and Related Cancers In South Africa
-
-
-
2
-
-
84877654469
-
Prophylactic HPV vaccination against cervical cancer: A summarised resource for clinicians
-
South African HPV Advisory Board
-
South African HPV Advisory Board. Prophylactic HPV vaccination against cervical cancer: a summarised resource for clinicians. S Afr J Gynaecol Oncol 2011;3(1):39-42.
-
(2011)
S Afr J Gynaecol Oncol
, vol.3
, Issue.1
, pp. 39-42
-
-
-
4
-
-
84877648895
-
Human papillomavirus infections: Epidemiology, clinical aspects and vaccines
-
Denny L. Human papillomavirus infections: Epidemiology, clinical aspects and vaccines. The Open Infectious Diseases Journal 2009;3:135-142.
-
(2009)
The Open Infectious Diseases Journal
, vol.3
, pp. 135-142
-
-
Denny, L.1
-
6
-
-
85172059625
-
-
Merck & Co, (accessed 17 August
-
Merck & Co. Prescribing Information - Gardasil. 2011. http://www.gardasil.com (accessed 17 August 2012).
-
(2011)
Prescribing Information - Gardasil
-
-
-
7
-
-
70349775499
-
The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa
-
Sinanovic E, Moodley J, Barone MA, Mall S, Cleary S, Harries J. The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa. Vaccine 2009;27(44):6196-6202. [http://dx.doi.org/10.1016/j.vaccine.2009.08.004]
-
(2009)
Vaccine
, vol.27
, Issue.44
, pp. 6196-6202
-
-
Sinanovic, E.1
Moodley, J.2
Barone, M.A.3
Mall, S.4
Cleary, S.5
Harries, J.6
-
8
-
-
2342613014
-
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine
-
Goldie SJ, Kohli M, Grima D, et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst 2004;96(8):604-615. [http://dx.doi.org/10.1093/jnci/djh104]
-
(2004)
J Natl Cancer Inst
, vol.96
, Issue.8
, pp. 604-615
-
-
Goldie, S.J.1
Kohli, M.2
Grima, D.3
-
9
-
-
85172062862
-
-
National Department of Health, Pretoria: National Department of Health
-
National Department of Health. Vaccinators Manual 2005. Pretoria: National Department of Health, 2005.
-
(2005)
Vaccinators Manual 2005
-
-
-
11
-
-
84877686174
-
-
Zululand District Municipality, (accessed 11 October
-
Zululand District Municipality. Draft Integrated Development Plan: 2012 - 2016. http://www.zululand.org.za/media/3109/ZDM%20Draft%20IDP%202012-2013_1.pdf (accessed 11 October 2012).
-
(2012)
Draft Integrated Development Plan: 2012 - 2016
-
-
-
12
-
-
85172059846
-
-
CIES, (accessed 11 October 2012)
-
CIES. Developing a Management Model for Cervical Cancer Vaccination. 2010. http://www.cervicalcanceraction.org/newsletters/2010-07/HPVvac_demoproj_Bolivia_Jan2010.pdf (accessed 11 October 2012).
-
(2010)
Developing a Management Model For Cervical Cancer Vaccination
-
-
-
14
-
-
80055108789
-
Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries
-
LaMontagne DS, Barge S, Le NT, et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ 2011;89:821-830B. [http://dx.doi.org/10.2471/BLT.11.08986]
-
(2011)
Bull World Health Organ
, vol.89
-
-
Lamontagne, D.S.1
Barge, S.2
Le, N.T.3
|